State policy and action news

The American Academy of Dermatology Association (AADA) is constantly working with state dermatology societies and state legislatures to introduce, support, or oppose bills that could affect your practice. Use the links below to read AADA comments about issues that matter to you and your patients.

2015

Alabama

 

 

Connecticut

AADA sent a letter of support for legislation which would adopt the AMA and American College of Surgeons definition of surgery. Read the letter here

AADA, ASDSA,  the American Society for Laser Medicine and Surgery, and the Connecticut Dermatology and Dermatologic Surgery Society sent a joint letter opposing legislation in Connecticut that would allow electrologists to perform laser hair removal without physician supervision. Read the letter here

Georgia

AADA sent a letter of support for legislation in Georgia which would require health care providers to wear identification badges that clearly identify name and license or educational degree.  The bill passed committee and awaits a house floor vote. Read the letter here

 

Idaho

In 2014, the Idaho Board of Pharmacy proposed regulations to allow for the substitution of biosimilars without physician notification. In accordance with the proposal, pharmacists would be authorized to substitute biosimilars for biologic drugs without notifying the health care provider. The AADA opposes recently passed legislation in Idaho that would implement the BOP's proposal  and continues to advocate for a physician notification provision. 
Most recently, AADA sent a letter of support for legislation which would which require a pharmacist to communicate to a physician that an interchangeable biosimilar has been substituted.

Indiana

AADA sent a letter of support for SB 492, legislation which would strengthen truth in advertising laws by requiring that all provider advertisements identify the type of professional license and board certification. The included a recommendation for an amendment that would allow the term “board-certified” be used in provider advertising only if materials include the full name of the certifying board member board of the American Board of Medical Specialties (ABMS) or the American Osteopathic Association (AOA), or has received graduate training by an approve accreditation body. The amendment was accepted. Read the letter here

Iowa

AADA sent two letters of support for legislation which would restrict minors under the age of 18 from using indoor tanning devices in Iowa. Read one of the letters here

Kentucky

AADA support legislation to prevent minors under 18 from using indoor tanning beds in Kentucky. Read the letter here

Maryland

AADA sent a letter of support for HB 56, legislation which would restrict minors under the age of 18 from using indoor tanning devices in a tanning facility. Several AADA members testified in favor of the legislation. Read the letter here

The Maryland legislature has also been considering legislation to authorize the dispensing of biosimilars.  AADA support bills in both chambers of the legislature, but has requested a friendly amendment to alter the physician communication time frame to "by the time of dispensing," as stated in the AADA position statement.  Read the letters here and here

Montana

AADA sent a letter of support for SB 125, legislation which would prevent minors from using indoor tanning devices.  Read the letter of support here. The Montana has also been reviewing a competing parental consent bill, SB 130. 

AADA submitted comments to the Montana Insurance Commissioner concerning draft network adequacy regulations.  The comments included six recommendations; read more here.

Nebraska

AADA sent a letter of support for legislation which would require individuals licensed under the Uniform Credentialing Act to clearly identify in any advertisement for their health care services the type of credential held. Additionally, LB 452 would prohibit any false or misleading advertising of one’s credentials. Read the letter here.

AADA recently opposed legislation in Nebraska which would authorize nurse practitioners to practice independently.  Read the letter here

New Hampshire

AADA sent a letter of support for HB 136, legislation which would prevent minors from using indoor tanning devices.  Read the letter here

 

Oregon

AADA sent a letter of support for legislation in Oregon which would authorize the dispensing of biosimilars.  In the letter, AADA requested a friendly amendment to alter the physician communication time frame to "by the time of dispensing," as stated in the AADA position statement.  Read the letter here.  

 

Rhode Island

 

AADA sent a letter of support for legislation in Rhode Island which would require insurers to maintain accurate directories of in-network providers.  Read the letter here

Tennessee

AADA sent a letter of support for legislation in Tennessee that would authorize the dispensing of biosimilars.  AADA included a recommendation for an amendment to ensure physicians are notified of the dispensed biosimilar by the time of dispensing, as stated in the AADA Position Statement on Generic Therapeutic and Biosimilar Substitution.